Bovie Medical Corp., a maker of medical devices and supplies, has entered into a sales channel agreement with Arteriocyte Medical Systems, Inc., to sell Bovie’s J-Plasma surgical product for cutting and coagulation to plastic surgeons.
J-Plasma utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery.
The agreement will significantly expand its potential for use in office-based practices, according to Bovie.
Arteriocyte Medical Systems, also a medical device company, develops products to help patients heal faster. Its lead product is the Magellan Autogous Platelet Separator system that provides surgeons the ability to separate peripheral blood or a combination of peripheral blood and bone marrow from a patient, for that patient, at bedside in approximately 15 minutes, according to the company.